Doctor Anywhere Secures USD38.8 Million Funding and Announces Acquisitionby Fintech News Singapore December 22, 2022
Doctor Anywhere (DA), a regional tech-led healthcare company headquartered in Singapore, announced that it has acquired Catalist-listed Asian Healthcare Specialists , an integrated healthcare provider in Singapore.
Asian Healthcare Specialists is a group of 14 medical specialists, with a patient-first approach and vision to make specialised care accessible to all. Its 12 specialist clinics across multidisciplinary specialities comprise orthopaedics, ophthalmology, dermatology, urology, gastroenterology, otorhinolaryngology, anaesthesia, family medicine and rehabilitation – all areas that complement DA’s regional healthcare services and offer consumers greater access to complex treatments.
The acquisition is a strategic step to further DA’s long-term growth ambitions, enabling it to deliver more holistic healthcare and meet the rising demand for complex, specialised treatment across Southeast Asia.
“Our goal at Doctor Anywhere is to build a digital healthcare ecosystem to enable better patient outcomes and help shape the future of healthcare in Southeast Asia. With consumers across the region seeking higher quality and more personalised care, the acquisition of Asian Healthcare Specialists strengthens our capabilities beyond our successful primary care services, enabling us to deliver more integrated, holistic care and greater value for our users,”
said Lim Wai Mun, Founder & CEO, Doctor Anywhere.
“We continue to be on the lookout for synergistic opportunities and targeted acquisitions of critical healthcare assets across the region, which will enable us to further the work we have begun on building a regional healthcare ecosystem that leverages technology and innovation. A more diversified and holistic range of integrated healthcare service offerings will enable Doctor Anywhere to deliver greater value and impact to elevate the region’s healthcare outcomes,”
added Wai Mun.
Chief Executive Officer of Asian Healthcare Specialists Limited, Dr Chin Pak Lin commented,
“Coupled with shifting demographics, technological innovations, and the diverse nature of healthcare infrastructure across Southeast Asia, we’re currently sitting at the nexus of potential transformation. We are excited to join Southeast Asia’s largest omni-channel healthcare provider and bring our well-established specialist care expertise to the group. We look forward to working together to bridge the gap between primary and specialised care to provide seamless, holistic care that transcends boundaries and statuses.”
Additional funding bolstered by latest Series C1 financing round
Doctor Anywhere also announced a US$38.8 million Series C1 financing round, an up round led by Novo Holdings, a leading international life science investor. Other existing shareholders also participated in the round, including Asia Partners, Kamet Capital, Square Peg, IHH Healthcare, EDBI and OSK-SBI Venture Partners.
The funding will be used to accelerate growth and to partly fund the acquisition of Asian Healthcare Specialists. It comes just over a year after the company raised a US$65.7 million Series C in August 2021 in one of the largest private funding rounds ever raised by a healthtech company in Southeast Asia. This brings the total capital raised by Doctor Anywhere to nearly US$140 million.